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Purpose: We present a patient with systemic lupus erythematosus with signiﬁcant vaso-occlusive retinal
ﬁndings mimicking antiphospholipid antibody syndrome, who developed Kikuchi-Fujimoto disease.
Observations: Our patient was initially diagnosed with systemic lupus erythematosus with anti-
phospholipid antibody syndrome given consistent serologic markers and profound retinal vascular
ischemia. However, on subsequent follow up, she presented with fever and lymphadenopathy and un-
derwent lymph node biopsy, which declared histologic ﬁndings of Kikuchi-Fujimoto disease. Repeat
markers for antiphospholipid antibody syndrome were negative and she was taken off lifelong
anticoagulation.
Conclusions and importance: Systemic lupus erythematosus and Kikuchi-Fujimoto disease may have
many similar features and even biomarkers, and given the potential overlap of presentation, clinicians
must carefully distinguish between these diseases to prevent unnecessary treatment.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Classically, Kikuchi-Fujimoto Disease (KFD) is characterized by
fever and tender lymphadenopathy, typically self-limited over a
period of a few months without treatment, often in young women
of Asian heritage.1,2 Systemic lupus erythematosus (SLE) and KFD
have been reported to occur in patients at any time interval,
including concurrently and sequentially to each other.3e5 We pre-
sent a case of a patient with SLE who presented with profound
retinal ischemia mimicking antiphospholipid antibody syndrome
(APLS), who developed KFD. Lymph node biopsy secured the
diagnosis of KFD. Furthermore, the patient’s initially elevated anti-
cardiolipin antibodies when she presented with lupus ﬂare were
negative on repeat testing for APLS when she presented with
clinical ﬁndings of KFD. This case did not require approval by our
Institutional Review Board.2. Case report
Speciﬁc personal identifying information has been removed
from this report in accordance with the patient’s wishes. A twenty-thalmology, 1450 San Pablo
ao).
Inc. This is an open access article usix-year old female, recently diagnosed and treated for SLE
complicated by aseptic meningitis and multiple small strokes at an
outside hospital 2 weeks prior, presented to our institution with
complaints of painless decreased vision and right visual ﬁeld deﬁcit
of the left eye (OS), occurring suddenly 12 days prior and without
improvement in the intervening period. Visual acuity (VA) was 20/
20 right eye (OD) and count ﬁngers at 1 foot OS. Pupils were equal,
round and reactive with a positive afferent pupillary defect OS.
Brightness sense was decreased OS compared to OD and she was
unable to perform color plates OS compared to 8/8 plates OD.
Intraocular pressures as well as anterior segment exam were
normal in both eyes (OU). Dilated fundus exam was signiﬁcant for
mild disc edema and a cotton wool spot along the superior arcade
OD (Fig. 1). There was severe disc edema with peripapillary hem-
orrhage OS and an apparent cherry red spot in the macula. The
vessels were sclerosed and sheathed, with many ghost vessels
visible. There was diffuse retinal ischemia and retinal hemorrhages
temporally in the periphery (Fig. 2). Optical coherence tomography
(OCT) showed nerve ﬁber layer thickening corresponding to cotton
wool spots. Fluorescein angiography (FA) demonstrated marked
ischemia with complete nonperfusion extending from the macula
(Fig. 3), in contrast to the normal perfusion in the right eye (Fig. 4).
Work up revealed positive ANA (1:160, speckled), anti-smith (>8),
anti-RNP (>8), SSA (3.1), anti-cardiolipin (26), with low C3 (39) and
C4 (8.3) and she was diagnosed with SLE with APLS. Hypercoagu-
lability workup including homocysteine, PT/INR, PTT were normal.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Color fundus photo, right eye. Dilated fundus exam of the right eye was signiﬁcant for mild disc edema and a cotton wool spot along the superior arcade.
Fig. 2. Color fundus photo, left eye. Dilated fundus exam of the left eye was remarkable for severe disc edema with peripapillary hemorrhage, an apparent cherry red spot in the
macula, sclerosed and sheathed vessels, diffuse retinal ischemia and retinal hemorrhages.
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Quantiferon Gold, blood cultures, chest X-ray, lumbar puncture,
and trans-esophageal echocardiogram. MRI was consistent with a
punctate left basal ganglia lacunar infarct. MRA was normal. She
was treated with high dose IV methylprednisolone starting at 1gmFig. 3. Fluorescein angiography, left eye. Fluorescein angiography demonstrated
marked ischemia with complete nonperfusion extending from the macula of the left
eye.for a day and quickly tapered due to presumed steroid-induced
psychosis to 500 mg for 2 days, then transitioned to prednisone
20mg every 8 hours, and shewas discharged on cyclophosphamide
and hydroxychloroquine because of perceived severity of her SLE,
and enoxaparin was transitioned to warfarin for life longFig. 4. Fluorescein angiography, right eye. Normal perfusion.
Fig. 5. Pathology slide of lymph node biopsy. Lymph node biopsy revealed signiﬁcant
necrosis (A) and broken nuclei signifying karyorrhectic debris (B).
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discharged.
She returned to the hospital approximately two months later
with recurrent fevers up to 102F, but extensive infectious work up
was negative. She was found to have hypermetabolic cervical
lymph nodes on PET-CT. Fine needle and core needle biopsy of
lymph nodes were not diagnostic, and ﬁnally a cervical node core
biopsy revealed histiocytic necrotizing lymphadenitis, consistent
with KFD (Fig. 5). Therewas nomorphologic or immunophenotypic
evidence of lymphoproliferative disorder. Given her KFD diagnosis,
APLS work up was repeated, which returned negative for anti-
cardiolipin, and she was taken off what we previously presumed
would be lifelong anticoagulation. Her fever and lymphadenopathy
resolved. Now medically stable, she was treated with panretinal
photocoagulation for retinal neovascularization and extensive
retinal ischemia.3. Discussion
We present retinal vascular changes in a patient initially diag-
nosed with SLE and APLS, which evolved to KFD.Fig. 6. Immunohistochemistry stain of lymph node biopsy demonstrating greater proportion
CD 8 þ T cells (B). CD 68 þ histiocytes (C).SLE retinopathy is characterized by retinal hemorrhages, cotton
wool spots, arteriolar narrowing, capillary dilation, venous dilation
and tortuosity, and retinal edema and exudates from immune-
complex vasculopathy.6 Less commonly, occlusive retinal vascu-
litis may develop resulting in diffuse capillary nonperfusion and
retinal ischemia.7 The mechanism is incompletely understood and
likely multifactorial, including immune-complex deposition,
vasculitis, arteriolar constriction with systemic hypertension, and
capillarymicrothrombosis.6e10 Arteriolar occlusion can then lead to
venous occlusion and neovascularization.6 Such severe vaso-
occlusive retinopathy is often associated with antiphospholipid
antibodies.11 By an unclear mechanism, these antibodies promote
thrombosis, which can lead to retinal vaso-occlusive disease.12e15
APLS can also present with venous tortuosity, ﬂame-shaped hem-
orrhages, microaneurysms, and cotton wool spots, presumably
from microvascular occlusion of immune complexes.16 In contrast,
ocularmanifestations of KFD are rare, with reports of lacrimal gland
inﬂammation, conjunctivitis, and panuveitis with peripheral retinal
vascular sheathing occurring before, concurrently or after
lymphadenopathy.17e19 There has been one report of arteriolar
occlusion, capillary nonperfusion, and resulting proliferative reti-
nopathy in a patient with negative serologic workup, who had been
diagnosed with KFD three days prior to onset of visual symptoms.20
Thus, it is possible inﬂammation from both SLE and KFD contrib-
uted to the severe retinal vaso-occlusion and resulting neo-
vascularization seen in our patient.
Classically, KFD is characterized by fever and tender lymph-
adenopathy, typically self-limited over a period of a few months
without known treatment, often in young women of Asian heri-
tage.1,2 There has been many hypotheses regarding the etiology of
KFD, including hyper-immune reaction to viruses or HLA genetic
susceptibility to excessive T cell mediated response, but none
proven.1,2 Diagnosis is based on excisional lymph node biopsy that
illustrates necrosis, karyorrhectic debris wherein nuclear chro-
matin fragments become distributed throughout the cytoplasm,
monocytes, CD 8þ T cells, and histiocytes that express MPO and CD
68, together with a lack of neutrophils, plasma cells, eosinophils, or
granulomas.1,21e24 Our patient’s lymph node biopsy revealed a
greater proportion of CD 8 to CD 4 T cells, as well as presence of CD
68 histiocytes, with the associated CD 4, CD 8, and CD 68 markers
seen on immunohistochemistry stains (Fig. 6). There was also sig-
niﬁcant cellular necrosis and karyorrhectic debris, which led to her
diagnosis of KFD (Fig. 5).
Though lupus lymphadenopathy was initially on our patient’s
differential diagnosis, she did not have features that are speciﬁc toof CD8þ to CD 4 þ T cells, as well as presence of CD 68 þ histiocytes. CD 4 þ T cells (A).
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demonstrate follicular hyperplasia, necrosis, and atypical lympho-
plasmacytic and immunoblastic proliferation.25 Necrotic lymph-
adenopathy is most similar to KFD and is characterized by many
lymphocytes, plasma, mononuclear and reticulum cells, few neu-
trophils, and rare eosinophils.26,27 There may be areas of necrosis
and inﬂammation, classifying it as necrotizing lymphadenitis with
granulocytic inﬁltration.28 However, pathognomonic to SLE
lymphadenopathy is the hematoxylin body, extracellular amor-
phous material, though not often seen.21e24,29 These H- bodies, a
neutrophilic inﬁltrate, and large plasma cells help to distinguish
SLE lymphadenopathy from KFD,21e24,29 and were not seen in our
patient.
SLE and KFD have been reported to occur together in patients at
any time interval, including concurrently and sequentially to each
other, for unknown reasons.3e5 There are even cases of KFD where
the patient presented with elevated biomarkers or symptoms
similar to SLE, but lupus was ultimately excluded in the diag-
nosis.30,31 Similarly, our patient initially had features of lupus and
APLS, which resolved on repeat testing for APLS when she pre-
sented with KFD. The transient elevated immune marker may have
heralded the impending KFD. Though retinal vasculopathy is more
often seenwith lupus, KFDmust also be considered in the diagnosis
when patients also present with lymphadenopathy.
4. Conclusion
Clinicians must be vigilant in the diagnosis and treatment of
such patients, as SLE and KFD may have many similar features and
even biomarkers. Given the potential overlap of pathology and
presentation, clinicians must distinguish between these diseases to
prevent unnecessary treatment for lupus when the disorder
evolves into KFD, which can be treated with supportive therapy, a
short course of steroids, NSAIDs, or hydroxychloroquine.1,2
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